Spectral Medical (EDT) Stock Price, News & Analysis

Company Overview

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.

Key Stats

• Today's Range: C$0.51 to C$0.53
• 50-Day Range: C$0.47 to C$0.59
• 52-Week Range: C$0.38 to C$0.75
• Volume: 8,559 shs
• Average Volume: 38,908 shs
• Market Capitalization: C$149.06 million
• P/E Ratio: N/A
• Dividend Yield: 1.45%
• Price Target: N/A
• Consensus Rating: N/A

EDT Stock Analysis - Frequently Asked Questions

How have EDT shares performed this year?

Spectral Medical's stock was trading at C$0.50 at the beginning of 2025. Since then, EDT shares have increased by 6.0% and is now trading at C$0.53.
View the best growth stocks for 2025 here.

How were Spectral Medical's earnings last quarter?

Spectral Medical Inc. (TSE:EDT) announced its quarterly earnings results on Friday, November, 8th. The company reported ($0.04) EPS for the quarter. The firm had revenue of $0.50 million for the quarter.

How do I buy shares of Spectral Medical?

Shares of EDT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Spectral Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Spectral Medical investors own include Oncolytics Biotech (ONC), Aurora Cannabis (ACB), Alamos Gold (AGI), BlackBerry (BB), Ballard Power Systems (BLDP), CENTRIC HEALTH (CHH) and Cequence Energy Ltd. (CQE.TO) (CQE).

Company Calendar

• Last Earnings: 11/08/2024
• Today: 2/01/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: TSE:EDT
• Previous Symbol: TSE:SDI
• CUSIP: N/A
• CIK: N/A
• Web: www.spectraldx.com
• Phone: +1-416-6263233
• Fax: N/A
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-18,680,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -973.97%
• Return on Assets: -93.22%

Debt

• Debt-to-Equity Ratio: 26.03
• Current Ratio: 0.61
• Quick Ratio: 0.45

Sales & Book Value

• Annual Sales: C$1.90 million
• Price / Sales: 78.45
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 82.50
• Book Value: C($0.08) per share
• Price / Book: -6.63

Miscellaneous

• Outstanding Shares: 281,250,000
• Free Float: N/A
• Market Cap: C$149.06 million
• Optionable: Not Optionable
• Beta: 0.96